ABSTRACT
Mycobacterium tuberculosis infection in humans triggers formation of granulomas, which are tightly organized immune cell aggregates that are the central structure of tuberculosis. Infected and uninfected macrophages interdigitate, assuming an altered, flattened appearance. Although pathologists have described these changes for over a century, the molecular and cellular programs underlying this transition are unclear. Here, using the zebrafish-Mycobacterium marinum model, we found that mycobacterial granuloma formation is accompanied by macrophage induction of canonical epithelial molecules and structures. We identified fundamental macrophage reprogramming events that parallel E-cadherin-dependent mesenchymal-epithelial transitions. Macrophage-specific disruption of E-cadherin function resulted in disordered granuloma formation, enhanced immune cell access, decreased bacterial burden, and increased host survival, suggesting that the granuloma can also serve a bacteria-protective role. Granuloma macrophages in humans with tuberculosis were similarly transformed. Thus, during mycobacterial infection, granuloma macrophages are broadly reprogrammed by epithelial modules, and this reprogramming alters the trajectory of infection and the associated immune response.
Subject(s)
Epithelium/immunology , Macrophages/immunology , Mycobacterium marinum/immunology , Animals , Cadherins/immunology , Epithelium/microbiology , Granuloma/immunology , Granuloma/microbiology , Macrophages/microbiology , Mycobacterium tuberculosis/immunology , ZebrafishABSTRACT
Pathogenic mycobacteria induce the formation of complex cellular aggregates called granulomas that are the hallmark of tuberculosis. Here we examine the development and consequences of vascularization of the tuberculous granuloma in the zebrafish-Mycobacterium marinum infection model, which is characterized by organized granulomas with necrotic cores that bear striking resemblance to those of human tuberculosis. Using intravital microscopy in the transparent larval zebrafish, we show that granuloma formation is intimately associated with angiogenesis. The initiation of angiogenesis in turn coincides with the generation of local hypoxia and transcriptional induction of the canonical pro-angiogenic molecule Vegfaa. Pharmacological inhibition of the Vegf pathway suppresses granuloma-associated angiogenesis, reduces infection burden and limits dissemination. Moreover, anti-angiogenic therapies synergize with the first-line anti-tubercular antibiotic rifampicin, as well as with the antibiotic metronidazole, which targets hypoxic bacterial populations. Our data indicate that mycobacteria induce granuloma-associated angiogenesis, which promotes mycobacterial growth and increases spread of infection to new tissue sites. We propose the use of anti-angiogenic agents, now being used in cancer regimens, as a host-targeting tuberculosis therapy, particularly in extensively drug-resistant disease for which current antibiotic regimens are largely ineffective.
Subject(s)
Angiogenesis Inhibitors/pharmacology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium marinum/drug effects , Mycobacterium marinum/growth & development , Neovascularization, Pathologic/microbiology , Signal Transduction/drug effects , Zebrafish/microbiology , Angiogenesis Inhibitors/therapeutic use , Animals , Antibiotics, Antitubercular/pharmacology , Bacterial Load/drug effects , Disease Models, Animal , Drug Synergism , Granuloma/drug therapy , Granuloma/metabolism , Granuloma/microbiology , Granuloma/pathology , Hypoxia/metabolism , Hypoxia/microbiology , Hypoxia/pathology , Larva/drug effects , Larva/microbiology , Macrophages/metabolism , Macrophages/microbiology , Macrophages/pathology , Mycobacterium Infections, Nontuberculous/drug therapy , Mycobacterium Infections, Nontuberculous/metabolism , Mycobacterium Infections, Nontuberculous/pathology , Mycobacterium marinum/pathogenicity , Neovascularization, Pathologic/drug therapy , Receptors, Vascular Endothelial Growth Factor/antagonists & inhibitors , Receptors, Vascular Endothelial Growth Factor/metabolism , Tuberculosis/drug therapy , Tuberculosis/microbiology , Tuberculosis/pathology , Vascular Endothelial Growth Factor A/antagonists & inhibitors , Vascular Endothelial Growth Factor A/metabolism , Zebrafish/growth & developmentABSTRACT
The intestinal epithelium forms a barrier protecting the organism from microbes and other proinflammatory stimuli. The integrity of this barrier and the proper response to infection requires precise regulation of powerful immune homing signals such as tumor necrosis factor (TNF). Dysregulation of TNF leads to inflammatory bowel diseases (IBD), but the mechanism controlling the expression of this potent cytokine and the events that trigger the onset of chronic inflammation are unknown. Here, we show that loss of function of the epigenetic regulator ubiquitin-like protein containing PHD and RING finger domains 1 (uhrf1) in zebrafish leads to a reduction in tnfa promoter methylation and the induction of tnfa expression in intestinal epithelial cells (IECs). The increase in IEC tnfa levels is microbe-dependent and results in IEC shedding and apoptosis, immune cell recruitment, and barrier dysfunction, consistent with chronic inflammation. Importantly, tnfa knockdown in uhrf1 mutants restores IEC morphology, reduces cell shedding, and improves barrier function. We propose that loss of epigenetic repression and TNF induction in the intestinal epithelium can lead to IBD onset.
Subject(s)
DNA Methylation , Epigenesis, Genetic/physiology , Inflammatory Bowel Diseases/metabolism , Intestinal Mucosa/embryology , Zebrafish/embryology , Animals , Epithelial Cells/metabolism , Epithelial Cells/pathology , Inflammation/genetics , Inflammation/mortality , Inflammation/pathology , Inflammatory Bowel Diseases/genetics , Inflammatory Bowel Diseases/pathology , Intestinal Mucosa/pathology , Trans-Activators/genetics , Trans-Activators/metabolism , Tumor Necrosis Factor-alpha/immunology , Tumor Necrosis Factor-alpha/metabolism , Zebrafish/genetics , Zebrafish Proteins/genetics , Zebrafish Proteins/metabolismABSTRACT
Pathogenic mycobacteria trigger formation of organized granulomas. As granulomas mature, they induce angiogenesis and vascular permeability. Here, in a striking parallel to tumor pro-angiogenic signaling, we identify angiopoietin-2 (ANG-2) induction as an important component of vascular dysfunction during mycobacterial infection. Mycobacterial infection in humans and zebrafish results in robust induction of ANG-2 expression from macrophages and stromal cells. Using a small-molecule inhibitor closely related to one currently in clinical trials, we link ANG-2/TIE2 signaling to vascular permeability during mycobacterial infection. Targeting granuloma-induced vascular permeability via vascular endothelial-protein tyrosine phosphatase inhibition limits mycobacterial growth, suggesting a new strategy for host-directed therapies against tuberculosis.
Subject(s)
Angiopoietin-2/metabolism , Capillary Permeability , Mycobacterium Infections/pathology , Mycobacterium/growth & development , Angiopoietin-2/genetics , Animals , Animals, Genetically Modified , Disease Models, Animal , Gene Expression Regulation , Granuloma/microbiology , Host-Pathogen Interactions , Humans , Larva , Macrophages/drug effects , Macrophages/microbiology , Mycobacterium/drug effects , Receptor, TIE-2/metabolism , Signal Transduction , Tuberculosis/microbiology , ZebrafishABSTRACT
Mycobacterium tuberculosis is the leading worldwide cause of death due to a single infectious agent. Existing anti-tuberculous therapies require long treatments and are complicated by multi-drug-resistant strains. Host-directed therapies have been proposed as an orthogonal approach, but few have moved into clinical trials. Here, we use the zebrafish-Mycobacterium marinum infection model as a whole-animal screening platform to identify FDA-approved, host-directed compounds. We identify multiple compounds that modulate host immunity to limit mycobacterial disease, including the inexpensive, safe, and widely used drug clemastine. We find that clemastine alters macrophage calcium transients through potentiation of the purinergic receptor P2RX7. Host-directed drug activity in zebrafish larvae depends on both P2RX7 and inflammasome signaling. Thus, targeted activation of a P2RX7 axis provides a novel strategy for enhanced control of mycobacterial infections. Using a novel explant model, we find that clemastine is also effective within the complex granulomas that are the hallmark of mycobacterial infection.
Subject(s)
Antitubercular Agents/pharmacology , Clemastine/pharmacology , Granuloma/drug therapy , Mycobacterium Infections, Nontuberculous/drug therapy , Receptors, Purinergic P2X7/genetics , Zebrafish Proteins/genetics , Animals , Anti-Allergic Agents/pharmacology , Calcium/immunology , Calcium/metabolism , Disease Models, Animal , Drug Repositioning , Gene Expression Regulation , Granuloma/genetics , Granuloma/immunology , Granuloma/microbiology , Host-Pathogen Interactions/genetics , Host-Pathogen Interactions/immunology , Humans , Immunity, Innate/drug effects , Inflammasomes , Larva/drug effects , Larva/genetics , Larva/immunology , Larva/microbiology , Macrophages/drug effects , Macrophages/immunology , Macrophages/microbiology , Mycobacterium Infections, Nontuberculous/genetics , Mycobacterium Infections, Nontuberculous/immunology , Mycobacterium Infections, Nontuberculous/microbiology , Mycobacterium marinum/growth & development , Mycobacterium marinum/immunology , Mycobacterium marinum/pathogenicity , Mycobacterium tuberculosis/pathogenicity , Receptors, Purinergic P2X7/immunology , Signal Transduction , Tissue Culture Techniques , Tuberculosis, Pulmonary/drug therapy , Tuberculosis, Pulmonary/microbiology , Zebrafish/genetics , Zebrafish/immunology , Zebrafish/microbiology , Zebrafish Proteins/agonists , Zebrafish Proteins/immunologyABSTRACT
Academic medical centers rarely require all of their research faculty and staff to participate in educational programs on the responsible conduct of research (RCR). There is also little published evidence of RCR programs addressing high-profile, internal cases of misconduct as a way of promoting deliberation and learning. In the wake of major research misconduct, Duke University School of Medicine (DUSoM) expanded its RCR education activities to include all DUSoM faculty and staff engaged in research. The program included formal deliberation of the Translational Omics misconduct case, which occurred at Duke. Over 5,000 DUSoM faculty and staff participated in the first phase of this new program, with a 100% completion rate. The article reports on the program's development, challenges and successes, and future directions. This experience at Duke University illustrates that, although challenging and resource intensive, engagement with RCR activities can be integrated into programs for all research faculty and staff. Formal, participatory deliberation of recent cases of internal misconduct can add a novel dimension of reflection and openness to RCR educational activities.
Subject(s)
Curriculum , Schools, Medical , Scientific Misconduct , North Carolina , Program DevelopmentABSTRACT
Transgenic labeling of innate immune cell lineages within the larval zebrafish allows for real-time, in vivo analyses of microbial pathogenesis within a vertebrate host. To date, labeling of zebrafish macrophages has been relatively limited, with the most specific expression coming from the mpeg1 promoter. However, mpeg1 transcription at both endogenous and transgenic loci becomes attenuated in the presence of intracellular pathogens, including Salmonella typhimurium and Mycobacterium marinum. Here, we describe mfap4 as a macrophage-specific promoter capable of producing transgenic lines in which transgene expression within larval macrophages remains stable throughout several days of infection. Additionally, we have developed a novel macrophage-specific Cre transgenic line under the control of mfap4, enabling macrophage-specific expression using existing floxed transgenic lines. These tools enrich the repertoire of transgenic lines and promoters available for studying zebrafish macrophage dynamics during infection and inflammation and add flexibility to the design of future macrophage-specific transgenic lines.
Subject(s)
Host-Pathogen Interactions/genetics , Macrophages/microbiology , Mycobacterium Infections/genetics , Promoter Regions, Genetic/genetics , Zebrafish Proteins/genetics , Zebrafish/genetics , Zebrafish/microbiology , Animals , Animals, Genetically Modified/genetics , Animals, Genetically Modified/microbiology , Cell Lineage/genetics , Disease Models, Animal , Immunity, Innate/genetics , Larva/genetics , Larva/microbiology , Mycobacterium Infections/microbiology , Mycobacterium marinum/pathogenicity , Salmonella typhimurium/pathogenicity , Transgenes/geneticsABSTRACT
Calcium signaling has long been associated with key events of immunity, including chemotaxis, phagocytosis, and activation. However, imaging and manipulation of calcium flux in motile immune cells in live animals remain challenging. Using light-sheet microscopy for in vivo calcium imaging in zebrafish, we observe characteristic patterns of calcium flux triggered by distinct events, including phagocytosis of pathogenic bacteria and migration of neutrophils toward inflammatory stimuli. In contrast to findings from ex vivo studies, we observe enriched calcium influx at the leading edge of migrating neutrophils. To directly manipulate calcium dynamics in vivo, we have developed transgenic lines with cell-specific expression of the mammalian TRPV1 channel, enabling ligand-gated, reversible, and spatiotemporal control of calcium influx. We find that controlled calcium influx can function to help define the neutrophil's leading edge. Cell-specific TRPV1 expression may have broad utility for precise control of calcium dynamics in other immune cell types and organisms.
Subject(s)
Calcium Signaling/physiology , Microscopy, Fluorescence/methods , Neutrophils/metabolism , TRPV Cation Channels/metabolism , Animals , Animals, Genetically Modified , Calcium/metabolism , Chemotaxis/physiology , Rats , TRPV Cation Channels/genetics , ZebrafishSubject(s)
Calcium , TRPV Cation Channels/metabolism , Zebrafish Proteins/metabolism , Zebrafish , AnimalsABSTRACT
Fragile X Syndrome is caused by the silencing of the Fragile X Mental Retardation gene (FMR1). Regulating dosage of FMR1 levels is critical for proper development and function of the nervous system and germ line, but the pathways responsible for maintaining normal expression levels are less clearly defined. Loss of Drosophila Fragile X protein (dFMR1) causes several behavioral and developmental defects in the fly, many of which are analogous to those seen in Fragile X patients. Over-expression of dFMR1 also causes specific neuronal and behavioral abnormalities. We have found that Argonaute2 (Ago2), the core component of the small interfering RNA (siRNA) pathway, regulates dfmr1 expression. Previously, the relationship between dFMR1 and Ago2 was defined by their physical interaction and co-regulation of downstream targets. We have found that Ago2 and dFMR1 are also connected through a regulatory relationship. Ago2 mediated repression of dFMR1 prevents axon growth and branching defects of the Drosophila neuromuscular junction (NMJ). Consequently, the neurogenesis defects in larvae mutant for both dfmr1 and Ago2 mirror those in dfmr1 null mutants. The Ago2 null phenotype at the NMJ is rescued in animals carrying an Ago2 genomic rescue construct. However, animals carrying a mutant Ago2 allele that produces Ago2 with significantly reduced endoribonuclease catalytic activity are normal with respect to the NMJ phenotypes examined. dFMR1 regulation by Ago2 is also observed in the germ line causing a multiple oocyte in a single egg chamber mutant phenotype. We have identified Ago2 as a regulator of dfmr1 expression and have clarified an important developmental role for Ago2 in the nervous system and germ line that requires dfmr1 function.
Subject(s)
Drosophila Proteins/metabolism , Drosophila Proteins/physiology , Drosophila melanogaster/genetics , Fragile X Mental Retardation Protein/metabolism , Oogenesis/physiology , RNA-Induced Silencing Complex/physiology , Animals , Argonaute Proteins , Drosophila Proteins/genetics , Drosophila melanogaster/metabolism , Female , Fragile X Mental Retardation Protein/genetics , Gene Expression Regulation , Gene Silencing , Microscopy, Fluorescence/methods , Models, Biological , Motor Neurons/metabolism , Nervous System/metabolism , Neurons/metabolism , Phenotype , RNA, Small Interfering/metabolismABSTRACT
SV40 transforms cells through the action of two oncoproteins, large T antigen and small t antigen. Small t antigen targets phosphatase PP2A, while large T antigen stimulates cell proliferation and survival by action on multiple proteins, including the tumor suppressors Rb and p53. Large T antigen also binds components of the transcription initiation complex and several transcription factors. We examined global gene expression in SV40-transformed mouse embryo fibroblasts, and in enterocytes obtained from transgenic mice. SV40 transformation alters the expression of approximately 800 cellular genes in both systems. Much of this regulation is observed in both MEFs and enterocytes and is consistent with T antigen action on the Rb-E2F pathway. However, the regulation of many genes is cell-type specific, suggesting that unique signaling pathways are activated in different cell types upon transformation, and that the consequences of SV40 transformation depends on the type of cell targeted.